V
Market Data
$5.44+$0.26 (+5.02%)
VNDA · Last trade
Prev Close
$5.18
Range (29d)
$4.93 – $5.57
Recent Filings
- SCHEDULE 13G15.3 KBVanda Pharmaceuticals Inc.Aug 19, 6:32 PM ET·0001104659-26-098866
- SCHEDULE 13G8.8 KBVanda Pharmaceuticals Inc.Aug 13, 9:22 AM ET·0001167557-26-000170
- 10-Q7.2 MBVanda Pharmaceuticals Inc.Aug 6, 7:39 AM ET·0001628280-26-053855
- 8-K382.1 KBVanda Pharmaceuticals Inc.Aug 5, 4:04 PM ET·0001628280-26-053308
- 8-K166.6 KBVanda Pharmaceuticals Inc.Jun 5, 4:38 PM ET·0001628280-26-041298
- 10-Q6.4 MBVanda Pharmaceuticals Inc.May 7, 7:01 AM ET·0001628280-26-031667
- 8-K339.6 KBVanda Pharmaceuticals Inc.May 6, 4:06 PM ET·0001628280-26-031241
- 8-K240.0 KBVanda Pharmaceuticals Inc.Apr 22, 5:23 PM ET·0001628280-26-026642
- 8-K144.3 KBVanda Pharmaceuticals Inc.Apr 2, 4:30 PM ET·0001628280-26-023222
- 8-K146.3 KBVanda Pharmaceuticals Inc.Mar 10, 4:47 PM ET·0001628280-26-016516
Insiders
10- Baroldi PaoloSVP & Chief Medical Officer
- BATE KENNETHDirector
- Birznieks GuntherSVP, Business Development
- BLAIR JAMES C10% Owner
- CARE CAPITAL II LLC10% Owner
- CARE CAPITAL INVESTMENTS II LP10% Owner
- Chrousos PhaedraDirector
- Clark William DSr. VP, Chief Business Officer
- COLA MICHAEL FDirector
- DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Member of 10% Group
Tickers
Addresses
business
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037
mailing
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037